Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
NGS-based RNA-seq market report explains the definition, types, applications, major countries, and major players of the NGS-based RNA-seq market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
BGI
Thermo Fisher Scientific
Roche
Eurofins Scientific
Macrogen
Illumina
GATC Biotech
Oxford Nanopore Technologies
Agilent Technologies
PerkinElmer
Pacific Biosciences of California
QIAGEN
By Type:
Sample Preparation
Sample Preparation
by Method
Sequencing Platforms & Consumables for RNA-Seq
RNA Sequencing Services
Data Analysis
Storage
and Management
By End-User:
De Novo Transcriptome Assembly
Expression Profiling Analysis
Variant Calling and Transcriptome Epigenetics
Small RNA Sequencing
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global NGS-based RNA-seq Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 NGS-based RNA-seq Outlook to 2028- Original Forecasts
-
2.2 NGS-based RNA-seq Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term NGS-based RNA-seq Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global NGS-based RNA-seq Market- Recent Developments
-
6.1 NGS-based RNA-seq Market News and Developments
-
6.2 NGS-based RNA-seq Market Deals Landscape
7 NGS-based RNA-seq Raw Materials and Cost Structure Analysis
-
7.1 NGS-based RNA-seq Key Raw Materials
-
7.2 NGS-based RNA-seq Price Trend of Key Raw Materials
-
7.3 NGS-based RNA-seq Key Suppliers of Raw Materials
-
7.4 NGS-based RNA-seq Market Concentration Rate of Raw Materials
-
7.5 NGS-based RNA-seq Cost Structure Analysis
-
7.5.1 NGS-based RNA-seq Raw Materials Analysis
-
7.5.2 NGS-based RNA-seq Labor Cost Analysis
-
7.5.3 NGS-based RNA-seq Manufacturing Expenses Analysis
8 Global NGS-based RNA-seq Import and Export Analysis (Top 10 Countries)
-
8.1 Global NGS-based RNA-seq Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global NGS-based RNA-seq Export by Region (Top 10 Countries) (2017-2028)
9 Global NGS-based RNA-seq Market Outlook by Types and Applications to 2022
-
9.1 Global NGS-based RNA-seq Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Sample Preparation Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Sample Preparation Consumption and Growth Rate (2017-2022)
-
9.1.3 Global by Method Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Sequencing Platforms & Consumables for RNA-Seq Consumption and Growth Rate (2017-2022)
-
9.1.5 Global RNA Sequencing Services Consumption and Growth Rate (2017-2022)
-
9.1.6 Global Data Analysis Consumption and Growth Rate (2017-2022)
-
9.1.7 Global Storage Consumption and Growth Rate (2017-2022)
-
9.1.8 Global and Management Consumption and Growth Rate (2017-2022)
-
9.2 Global NGS-based RNA-seq Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global De Novo Transcriptome Assembly Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Expression Profiling Analysis Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Variant Calling and Transcriptome Epigenetics Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Small RNA Sequencing Consumption and Growth Rate (2017-2022)
10 Region and Country-wise NGS-based RNA-seq Market Analysis and Outlook till 2022
-
10.1 Global NGS-based RNA-seq Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States NGS-based RNA-seq Consumption (2017-2022)
-
10.2.2 Canada NGS-based RNA-seq Consumption (2017-2022)
-
10.2.3 Mexico NGS-based RNA-seq Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany NGS-based RNA-seq Consumption (2017-2022)
-
10.3.2 UK NGS-based RNA-seq Consumption (2017-2022)
-
10.3.3 Spain NGS-based RNA-seq Consumption (2017-2022)
-
10.3.4 Belgium NGS-based RNA-seq Consumption (2017-2022)
-
10.3.5 France NGS-based RNA-seq Consumption (2017-2022)
-
10.3.6 Italy NGS-based RNA-seq Consumption (2017-2022)
-
10.3.7 Denmark NGS-based RNA-seq Consumption (2017-2022)
-
10.3.8 Finland NGS-based RNA-seq Consumption (2017-2022)
-
10.3.9 Norway NGS-based RNA-seq Consumption (2017-2022)
-
10.3.10 Sweden NGS-based RNA-seq Consumption (2017-2022)
-
10.3.11 Poland NGS-based RNA-seq Consumption (2017-2022)
-
10.3.12 Russia NGS-based RNA-seq Consumption (2017-2022)
-
10.3.13 Turkey NGS-based RNA-seq Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China NGS-based RNA-seq Consumption (2017-2022)
-
10.4.2 Japan NGS-based RNA-seq Consumption (2017-2022)
-
10.4.3 India NGS-based RNA-seq Consumption (2017-2022)
-
10.4.4 South Korea NGS-based RNA-seq Consumption (2017-2022)
-
10.4.5 Pakistan NGS-based RNA-seq Consumption (2017-2022)
-
10.4.6 Bangladesh NGS-based RNA-seq Consumption (2017-2022)
-
10.4.7 Indonesia NGS-based RNA-seq Consumption (2017-2022)
-
10.4.8 Thailand NGS-based RNA-seq Consumption (2017-2022)
-
10.4.9 Singapore NGS-based RNA-seq Consumption (2017-2022)
-
10.4.10 Malaysia NGS-based RNA-seq Consumption (2017-2022)
-
10.4.11 Philippines NGS-based RNA-seq Consumption (2017-2022)
-
10.4.12 Vietnam NGS-based RNA-seq Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil NGS-based RNA-seq Consumption (2017-2022)
-
10.5.2 Colombia NGS-based RNA-seq Consumption (2017-2022)
-
10.5.3 Chile NGS-based RNA-seq Consumption (2017-2022)
-
10.5.4 Argentina NGS-based RNA-seq Consumption (2017-2022)
-
10.5.5 Venezuela NGS-based RNA-seq Consumption (2017-2022)
-
10.5.6 Peru NGS-based RNA-seq Consumption (2017-2022)
-
10.5.7 Puerto Rico NGS-based RNA-seq Consumption (2017-2022)
-
10.5.8 Ecuador NGS-based RNA-seq Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain NGS-based RNA-seq Consumption (2017-2022)
-
10.6.2 Kuwait NGS-based RNA-seq Consumption (2017-2022)
-
10.6.3 Oman NGS-based RNA-seq Consumption (2017-2022)
-
10.6.4 Qatar NGS-based RNA-seq Consumption (2017-2022)
-
10.6.5 Saudi Arabia NGS-based RNA-seq Consumption (2017-2022)
-
10.6.6 United Arab Emirates NGS-based RNA-seq Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria NGS-based RNA-seq Consumption (2017-2022)
-
10.7.2 South Africa NGS-based RNA-seq Consumption (2017-2022)
-
10.7.3 Egypt NGS-based RNA-seq Consumption (2017-2022)
-
10.7.4 Algeria NGS-based RNA-seq Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia NGS-based RNA-seq Consumption (2017-2022)
-
10.8.2 New Zealand NGS-based RNA-seq Consumption (2017-2022)
11 Global NGS-based RNA-seq Competitive Analysis
-
11.1 BGI
-
11.1.1 BGI Company Details
-
11.1.2 BGI NGS-based RNA-seq Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 BGI NGS-based RNA-seq Main Business and Markets Served
-
11.1.4 BGI NGS-based RNA-seq Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Thermo Fisher Scientific
-
11.2.1 Thermo Fisher Scientific Company Details
-
11.2.2 Thermo Fisher Scientific NGS-based RNA-seq Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Thermo Fisher Scientific NGS-based RNA-seq Main Business and Markets Served
-
11.2.4 Thermo Fisher Scientific NGS-based RNA-seq Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Roche
-
11.3.1 Roche Company Details
-
11.3.2 Roche NGS-based RNA-seq Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Roche NGS-based RNA-seq Main Business and Markets Served
-
11.3.4 Roche NGS-based RNA-seq Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Eurofins Scientific
-
11.4.1 Eurofins Scientific Company Details
-
11.4.2 Eurofins Scientific NGS-based RNA-seq Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Eurofins Scientific NGS-based RNA-seq Main Business and Markets Served
-
11.4.4 Eurofins Scientific NGS-based RNA-seq Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Macrogen
-
11.5.1 Macrogen Company Details
-
11.5.2 Macrogen NGS-based RNA-seq Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Macrogen NGS-based RNA-seq Main Business and Markets Served
-
11.5.4 Macrogen NGS-based RNA-seq Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 Illumina
-
11.6.1 Illumina Company Details
-
11.6.2 Illumina NGS-based RNA-seq Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 Illumina NGS-based RNA-seq Main Business and Markets Served
-
11.6.4 Illumina NGS-based RNA-seq Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 GATC Biotech
-
11.7.1 GATC Biotech Company Details
-
11.7.2 GATC Biotech NGS-based RNA-seq Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 GATC Biotech NGS-based RNA-seq Main Business and Markets Served
-
11.7.4 GATC Biotech NGS-based RNA-seq Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Oxford Nanopore Technologies
-
11.8.1 Oxford Nanopore Technologies Company Details
-
11.8.2 Oxford Nanopore Technologies NGS-based RNA-seq Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Oxford Nanopore Technologies NGS-based RNA-seq Main Business and Markets Served
-
11.8.4 Oxford Nanopore Technologies NGS-based RNA-seq Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 Agilent Technologies
-
11.9.1 Agilent Technologies Company Details
-
11.9.2 Agilent Technologies NGS-based RNA-seq Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 Agilent Technologies NGS-based RNA-seq Main Business and Markets Served
-
11.9.4 Agilent Technologies NGS-based RNA-seq Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 PerkinElmer
-
11.10.1 PerkinElmer Company Details
-
11.10.2 PerkinElmer NGS-based RNA-seq Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 PerkinElmer NGS-based RNA-seq Main Business and Markets Served
-
11.10.4 PerkinElmer NGS-based RNA-seq Product Portfolio
-
11.10.5 Recent Research and Development Strategies
-
11.11 Pacific Biosciences of California
-
11.11.1 Pacific Biosciences of California Company Details
-
11.11.2 Pacific Biosciences of California NGS-based RNA-seq Sales, Price, Value and Gross Profit (2017-2022)
-
11.11.3 Pacific Biosciences of California NGS-based RNA-seq Main Business and Markets Served
-
11.11.4 Pacific Biosciences of California NGS-based RNA-seq Product Portfolio
-
11.11.5 Recent Research and Development Strategies
-
11.12 QIAGEN
-
11.12.1 QIAGEN Company Details
-
11.12.2 QIAGEN NGS-based RNA-seq Sales, Price, Value and Gross Profit (2017-2022)
-
11.12.3 QIAGEN NGS-based RNA-seq Main Business and Markets Served
-
11.12.4 QIAGEN NGS-based RNA-seq Product Portfolio
-
11.12.5 Recent Research and Development Strategies
12 Global NGS-based RNA-seq Market Outlook by Types and Applications to 2028
-
12.1 Global NGS-based RNA-seq Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Sample Preparation Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Sample Preparation Consumption Forecast and Growth Rate (2022-2028)
-
12.1.3 Global by Method Consumption Forecast and Growth Rate (2022-2028)
-
12.1.4 Global Sequencing Platforms & Consumables for RNA-Seq Consumption Forecast and Growth Rate (2022-2028)
-
12.1.5 Global RNA Sequencing Services Consumption Forecast and Growth Rate (2022-2028)
-
12.1.6 Global Data Analysis Consumption Forecast and Growth Rate (2022-2028)
-
12.1.7 Global Storage Consumption Forecast and Growth Rate (2022-2028)
-
12.1.8 Global and Management Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global NGS-based RNA-seq Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global De Novo Transcriptome Assembly Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Expression Profiling Analysis Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Variant Calling and Transcriptome Epigenetics Consumption Forecast and Growth Rate (2022-2028)
-
12.2.4 Global Small RNA Sequencing Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise NGS-based RNA-seq Market Analysis and Outlook to 2028
-
13.1 Global NGS-based RNA-seq Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States NGS-based RNA-seq Consumption Forecast (2022-2028)
-
13.2.2 Canada NGS-based RNA-seq Consumption Forecast (2022-2028)
-
13.2.3 Mexico NGS-based RNA-seq Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany NGS-based RNA-seq Consumption Forecast (2022-2028)
-
13.3.2 UK NGS-based RNA-seq Consumption Forecast (2022-2028)
-
13.3.3 Spain NGS-based RNA-seq Consumption Forecast (2022-2028)
-
13.3.4 Belgium NGS-based RNA-seq Consumption Forecast (2022-2028)
-
13.3.5 France NGS-based RNA-seq Consumption Forecast (2022-2028)
-
13.3.6 Italy NGS-based RNA-seq Consumption Forecast (2022-2028)
-
13.3.7 Denmark NGS-based RNA-seq Consumption Forecast (2022-2028)
-
13.3.8 Finland NGS-based RNA-seq Consumption Forecast (2022-2028)
-
13.3.9 Norway NGS-based RNA-seq Consumption Forecast (2022-2028)
-
13.3.10 Sweden NGS-based RNA-seq Consumption Forecast (2022-2028)
-
13.3.11 Poland NGS-based RNA-seq Consumption Forecast (2022-2028)
-
13.3.12 Russia NGS-based RNA-seq Consumption Forecast (2022-2028)
-
13.3.13 Turkey NGS-based RNA-seq Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China NGS-based RNA-seq Consumption Forecast (2022-2028)
-
13.4.2 Japan NGS-based RNA-seq Consumption Forecast (2022-2028)
-
13.4.3 India NGS-based RNA-seq Consumption Forecast (2022-2028)
-
13.4.4 South Korea NGS-based RNA-seq Consumption Forecast (2022-2028)
-
13.4.5 Pakistan NGS-based RNA-seq Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh NGS-based RNA-seq Consumption Forecast (2022-2028)
-
13.4.7 Indonesia NGS-based RNA-seq Consumption Forecast (2022-2028)
-
13.4.8 Thailand NGS-based RNA-seq Consumption Forecast (2022-2028)
-
13.4.9 Singapore NGS-based RNA-seq Consumption Forecast (2022-2028)
-
13.4.10 Malaysia NGS-based RNA-seq Consumption Forecast (2022-2028)
-
13.4.11 Philippines NGS-based RNA-seq Consumption Forecast (2022-2028)
-
13.4.12 Vietnam NGS-based RNA-seq Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil NGS-based RNA-seq Consumption Forecast (2022-2028)
-
13.5.2 Colombia NGS-based RNA-seq Consumption Forecast (2022-2028)
-
13.5.3 Chile NGS-based RNA-seq Consumption Forecast (2022-2028)
-
13.5.4 Argentina NGS-based RNA-seq Consumption Forecast (2022-2028)
-
13.5.5 Venezuela NGS-based RNA-seq Consumption Forecast (2022-2028)
-
13.5.6 Peru NGS-based RNA-seq Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico NGS-based RNA-seq Consumption Forecast (2022-2028)
-
13.5.8 Ecuador NGS-based RNA-seq Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain NGS-based RNA-seq Consumption Forecast (2022-2028)
-
13.6.2 Kuwait NGS-based RNA-seq Consumption Forecast (2022-2028)
-
13.6.3 Oman NGS-based RNA-seq Consumption Forecast (2022-2028)
-
13.6.4 Qatar NGS-based RNA-seq Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia NGS-based RNA-seq Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates NGS-based RNA-seq Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria NGS-based RNA-seq Consumption Forecast (2022-2028)
-
13.7.2 South Africa NGS-based RNA-seq Consumption Forecast (2022-2028)
-
13.7.3 Egypt NGS-based RNA-seq Consumption Forecast (2022-2028)
-
13.7.4 Algeria NGS-based RNA-seq Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia NGS-based RNA-seq Consumption Forecast (2022-2028)
-
13.8.2 New Zealand NGS-based RNA-seq Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of NGS-based RNA-seq
-
Figure of NGS-based RNA-seq Picture
-
Table Global NGS-based RNA-seq Import by Region (Top 10 Countries) (2017-2028)
-
Table Global NGS-based RNA-seq Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Sample Preparation Consumption and Growth Rate (2017-2022)
-
Figure Global Sample Preparation Consumption and Growth Rate (2017-2022)
-
Figure Global by Method Consumption and Growth Rate (2017-2022)
-
Figure Global Sequencing Platforms & Consumables for RNA-Seq Consumption and Growth Rate (2017-2022)
-
Figure Global RNA Sequencing Services Consumption and Growth Rate (2017-2022)
-
Figure Global Data Analysis Consumption and Growth Rate (2017-2022)
-
Figure Global Storage Consumption and Growth Rate (2017-2022)
-
Figure Global and Management Consumption and Growth Rate (2017-2022)
-
Figure Global De Novo Transcriptome Assembly Consumption and Growth Rate (2017-2022)
-
Figure Global Expression Profiling Analysis Consumption and Growth Rate (2017-2022)
-
Figure Global Variant Calling and Transcriptome Epigenetics Consumption and Growth Rate (2017-2022)
-
Figure Global Small RNA Sequencing Consumption and Growth Rate (2017-2022)
-
Figure Global NGS-based RNA-seq Consumption by Country (2017-2022)
-
Table North America NGS-based RNA-seq Consumption by Country (2017-2022)
-
Figure United States NGS-based RNA-seq Consumption and Growth Rate (2017-2022)
-
Figure Canada NGS-based RNA-seq Consumption and Growth Rate (2017-2022)
-
Figure Mexico NGS-based RNA-seq Consumption and Growth Rate (2017-2022)
-
Table Europe NGS-based RNA-seq Consumption by Country (2017-2022)
-
Figure Germany NGS-based RNA-seq Consumption and Growth Rate (2017-2022)
-
Figure UK NGS-based RNA-seq Consumption and Growth Rate (2017-2022)
-
Figure Spain NGS-based RNA-seq Consumption and Growth Rate (2017-2022)
-
Figure Belgium NGS-based RNA-seq Consumption and Growth Rate (2017-2022)
-
Figure France NGS-based RNA-seq Consumption and Growth Rate (2017-2022)
-
Figure Italy NGS-based RNA-seq Consumption and Growth Rate (2017-2022)
-
Figure Denmark NGS-based RNA-seq Consumption and Growth Rate (2017-2022)
-
Figure Finland NGS-based RNA-seq Consumption and Growth Rate (2017-2022)
-
Figure Norway NGS-based RNA-seq Consumption and Growth Rate (2017-2022)
-
Figure Sweden NGS-based RNA-seq Consumption and Growth Rate (2017-2022)
-
Figure Poland NGS-based RNA-seq Consumption and Growth Rate (2017-2022)
-
Figure Russia NGS-based RNA-seq Consumption and Growth Rate (2017-2022)
-
Figure Turkey NGS-based RNA-seq Consumption and Growth Rate (2017-2022)
-
Table APAC NGS-based RNA-seq Consumption by Country (2017-2022)
-
Figure China NGS-based RNA-seq Consumption and Growth Rate (2017-2022)
-
Figure Japan NGS-based RNA-seq Consumption and Growth Rate (2017-2022)
-
Figure India NGS-based RNA-seq Consumption and Growth Rate (2017-2022)
-
Figure South Korea NGS-based RNA-seq Consumption and Growth Rate (2017-2022)
-
Figure Pakistan NGS-based RNA-seq Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh NGS-based RNA-seq Consumption and Growth Rate (2017-2022)
-
Figure Indonesia NGS-based RNA-seq Consumption and Growth Rate (2017-2022)
-
Figure Thailand NGS-based RNA-seq Consumption and Growth Rate (2017-2022)
-
Figure Singapore NGS-based RNA-seq Consumption and Growth Rate (2017-2022)
-
Figure Malaysia NGS-based RNA-seq Consumption and Growth Rate (2017-2022)
-
Figure Philippines NGS-based RNA-seq Consumption and Growth Rate (2017-2022)
-
Figure Vietnam NGS-based RNA-seq Consumption and Growth Rate (2017-2022)
-
Table South America NGS-based RNA-seq Consumption by Country (2017-2022)
-
Figure Brazil NGS-based RNA-seq Consumption and Growth Rate (2017-2022)
-
Figure Colombia NGS-based RNA-seq Consumption and Growth Rate (2017-2022)
-
Figure Chile NGS-based RNA-seq Consumption and Growth Rate (2017-2022)
-
Figure Argentina NGS-based RNA-seq Consumption and Growth Rate (2017-2022)
-
Figure Venezuela NGS-based RNA-seq Consumption and Growth Rate (2017-2022)
-
Figure Peru NGS-based RNA-seq Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico NGS-based RNA-seq Consumption and Growth Rate (2017-2022)
-
Figure Ecuador NGS-based RNA-seq Consumption and Growth Rate (2017-2022)
-
Table GCC NGS-based RNA-seq Consumption by Country (2017-2022)
-
Figure Bahrain NGS-based RNA-seq Consumption and Growth Rate (2017-2022)
-
Figure Kuwait NGS-based RNA-seq Consumption and Growth Rate (2017-2022)
-
Figure Oman NGS-based RNA-seq Consumption and Growth Rate (2017-2022)
-
Figure Qatar NGS-based RNA-seq Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia NGS-based RNA-seq Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates NGS-based RNA-seq Consumption and Growth Rate (2017-2022)
-
Table Africa NGS-based RNA-seq Consumption by Country (2017-2022)
-
Figure Nigeria NGS-based RNA-seq Consumption and Growth Rate (2017-2022)
-
Figure South Africa NGS-based RNA-seq Consumption and Growth Rate (2017-2022)
-
Figure Egypt NGS-based RNA-seq Consumption and Growth Rate (2017-2022)
-
Figure Algeria NGS-based RNA-seq Consumption and Growth Rate (2017-2022)
-
Table Oceania NGS-based RNA-seq Consumption by Country (2017-2022)
-
Figure Australia NGS-based RNA-seq Consumption and Growth Rate (2017-2022)
-
Figure New Zealand NGS-based RNA-seq Consumption and Growth Rate (2017-2022)
-
Table BGI Company Details
-
Table BGI NGS-based RNA-seq Sales, Price, Value and Gross Profit (2017-2022)
-
Table BGI NGS-based RNA-seq Main Business and Markets Served
-
Table BGI NGS-based RNA-seq Product Portfolio
-
Table Thermo Fisher Scientific Company Details
-
Table Thermo Fisher Scientific NGS-based RNA-seq Sales, Price, Value and Gross Profit (2017-2022)
-
Table Thermo Fisher Scientific NGS-based RNA-seq Main Business and Markets Served
-
Table Thermo Fisher Scientific NGS-based RNA-seq Product Portfolio
-
Table Roche Company Details
-
Table Roche NGS-based RNA-seq Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche NGS-based RNA-seq Main Business and Markets Served
-
Table Roche NGS-based RNA-seq Product Portfolio
-
Table Eurofins Scientific Company Details
-
Table Eurofins Scientific NGS-based RNA-seq Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eurofins Scientific NGS-based RNA-seq Main Business and Markets Served
-
Table Eurofins Scientific NGS-based RNA-seq Product Portfolio
-
Table Macrogen Company Details
-
Table Macrogen NGS-based RNA-seq Sales, Price, Value and Gross Profit (2017-2022)
-
Table Macrogen NGS-based RNA-seq Main Business and Markets Served
-
Table Macrogen NGS-based RNA-seq Product Portfolio
-
Table Illumina Company Details
-
Table Illumina NGS-based RNA-seq Sales, Price, Value and Gross Profit (2017-2022)
-
Table Illumina NGS-based RNA-seq Main Business and Markets Served
-
Table Illumina NGS-based RNA-seq Product Portfolio
-
Table GATC Biotech Company Details
-
Table GATC Biotech NGS-based RNA-seq Sales, Price, Value and Gross Profit (2017-2022)
-
Table GATC Biotech NGS-based RNA-seq Main Business and Markets Served
-
Table GATC Biotech NGS-based RNA-seq Product Portfolio
-
Table Oxford Nanopore Technologies Company Details
-
Table Oxford Nanopore Technologies NGS-based RNA-seq Sales, Price, Value and Gross Profit (2017-2022)
-
Table Oxford Nanopore Technologies NGS-based RNA-seq Main Business and Markets Served
-
Table Oxford Nanopore Technologies NGS-based RNA-seq Product Portfolio
-
Table Agilent Technologies Company Details
-
Table Agilent Technologies NGS-based RNA-seq Sales, Price, Value and Gross Profit (2017-2022)
-
Table Agilent Technologies NGS-based RNA-seq Main Business and Markets Served
-
Table Agilent Technologies NGS-based RNA-seq Product Portfolio
-
Table PerkinElmer Company Details
-
Table PerkinElmer NGS-based RNA-seq Sales, Price, Value and Gross Profit (2017-2022)
-
Table PerkinElmer NGS-based RNA-seq Main Business and Markets Served
-
Table PerkinElmer NGS-based RNA-seq Product Portfolio
-
Table Pacific Biosciences of California Company Details
-
Table Pacific Biosciences of California NGS-based RNA-seq Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pacific Biosciences of California NGS-based RNA-seq Main Business and Markets Served
-
Table Pacific Biosciences of California NGS-based RNA-seq Product Portfolio
-
Table QIAGEN Company Details
-
Table QIAGEN NGS-based RNA-seq Sales, Price, Value and Gross Profit (2017-2022)
-
Table QIAGEN NGS-based RNA-seq Main Business and Markets Served
-
Table QIAGEN NGS-based RNA-seq Product Portfolio
-
Figure Global Sample Preparation Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Sample Preparation Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global by Method Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Sequencing Platforms & Consumables for RNA-Seq Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global RNA Sequencing Services Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Data Analysis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Storage Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global and Management Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global De Novo Transcriptome Assembly Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Expression Profiling Analysis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Variant Calling and Transcriptome Epigenetics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Small RNA Sequencing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global NGS-based RNA-seq Consumption Forecast by Country (2022-2028)
-
Table North America NGS-based RNA-seq Consumption Forecast by Country (2022-2028)
-
Figure United States NGS-based RNA-seq Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada NGS-based RNA-seq Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico NGS-based RNA-seq Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe NGS-based RNA-seq Consumption Forecast by Country (2022-2028)
-
Figure Germany NGS-based RNA-seq Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK NGS-based RNA-seq Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain NGS-based RNA-seq Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium NGS-based RNA-seq Consumption Forecast and Growth Rate (2022-2028)
-
Figure France NGS-based RNA-seq Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy NGS-based RNA-seq Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark NGS-based RNA-seq Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland NGS-based RNA-seq Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway NGS-based RNA-seq Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden NGS-based RNA-seq Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland NGS-based RNA-seq Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia NGS-based RNA-seq Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey NGS-based RNA-seq Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC NGS-based RNA-seq Consumption Forecast by Country (2022-2028)
-
Figure China NGS-based RNA-seq Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan NGS-based RNA-seq Consumption Forecast and Growth Rate (2022-2028)
-
Figure India NGS-based RNA-seq Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea NGS-based RNA-seq Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan NGS-based RNA-seq Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh NGS-based RNA-seq Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia NGS-based RNA-seq Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand NGS-based RNA-seq Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore NGS-based RNA-seq Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia NGS-based RNA-seq Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines NGS-based RNA-seq Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam NGS-based RNA-seq Consumption Forecast and Growth Rate (2022-2028)
-
Table South America NGS-based RNA-seq Consumption Forecast by Country (2022-2028)
-
Figure Brazil NGS-based RNA-seq Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia NGS-based RNA-seq Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile NGS-based RNA-seq Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina NGS-based RNA-seq Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela NGS-based RNA-seq Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru NGS-based RNA-seq Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico NGS-based RNA-seq Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador NGS-based RNA-seq Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC NGS-based RNA-seq Consumption Forecast by Country (2022-2028)
-
Figure Bahrain NGS-based RNA-seq Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait NGS-based RNA-seq Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman NGS-based RNA-seq Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar NGS-based RNA-seq Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia NGS-based RNA-seq Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates NGS-based RNA-seq Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa NGS-based RNA-seq Consumption Forecast by Country (2022-2028)
-
Figure Nigeria NGS-based RNA-seq Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa NGS-based RNA-seq Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt NGS-based RNA-seq Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria NGS-based RNA-seq Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania NGS-based RNA-seq Consumption Forecast by Country (2022-2028)
-
Figure Australia NGS-based RNA-seq Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand NGS-based RNA-seq Consumption Forecast and Growth Rate (2022-2028)
-
